Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Haemonetics Corp (NYSE:HAE)

37.66
Delayed Data
As of Feb 22
 -0.47 / -1.23%
Today’s Change
25.98
Today|||52-Week Range
41.65
-6.32%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues243.2M210.0M220.3M227.8M
 
 
 
 
 
Cost of Goods Sold131.8M95.3M93.3M104.5M
 
 
 
 
 
Depreciation And Amortization22.2M22.5M22.7M22.3M
 
 
 
 
 
 
Operating ExpensesGross Income89.2M92.2M104.2M101.1M
 
 
 
 
 
General Expenses82.3M82.6M77.9M72.7M
 
 
 
 
 
Research And Development11.7M11.4M8.3M8.5M
 
 
 
 
 
Total Operating Expenses236.3M200.4M193.9M199.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income6.8M9.6M26.4M28.4M
 
 
 
 
 
Extraordinary Credit0.00----2.0M
 
 
Extraordinary Charge-12.4M-17.7M-2.0M-7.2M
 
 
 
 
 
Interest Expense On Debt2.7M1.9M1.6M4.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-8.3M-10.1M22.8M18.9M
 
 
 
 
 
Income Taxes-467.0K-288.0K-3.0M-3.5M
 
 
 
 
 
Net Income-8.8M-10.3M19.8M15.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS50.9M51.0M51.4M51.7M
 
 
 
 
 
Shares To Calculate EPS Diluted50.9M51.0M51.7M52.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.17-$0.20$0.38$0.30
 
 
 
 
 
EPS Diluted-$0.17-$0.20$0.38$0.30